Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ishares A.I. Innovation and Tech Active ETF (BAI)

Ishares A.I. Innovation and Tech Active ETF (BAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 12,175,789,600
  • Shares Outstanding, K 298,280
  • 60-Month Beta 1.94
  • Price/Earnings ttm 50.00
  • Annual Dividend & Yield 0.60 (1.46%)
  • Most Recent Dividend 0.593 on 12/16/25
  • Management Fee 0.55%

Options Overview Details

View History
  • Implied Volatility 34.91% (-0.93%)
  • Historical Volatility 44.58%
  • IV Percentile 19%
  • IV Rank 29.06%
  • IV High 98.54% on 02/05/26
  • IV Low 8.84% on 09/02/25
  • Expected Move (DTE 25) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 59
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 677
  • Open Int (30-Day) 598
  • Expected Range 40.82 to 40.82

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.87 +32.23%
on 03/30/26
40.85 -0.07%
on 04/17/26
+6.52 (+19.01%)
since 03/17/26
3-Month
30.87 +32.23%
on 03/30/26
40.85 -0.07%
on 04/17/26
+5.92 (+16.96%)
since 01/16/26
52-Week
19.70 +107.21%
on 04/21/25
40.85 -0.07%
on 04/17/26
+20.32 (+99.12%)
since 04/17/25

Most Recent Stories

More News
3 AI ETFs That Let You Invest in the Entire AI Boom at Once

With returns of at least 49% in the last year, these high-momentum AI ETFs can help investors to easily broaden their exposure to the industry.

NVDA : 201.68 (+1.68%)
NUKZ : 73.10 (+1.70%)
ARTY : 58.65 (+1.73%)
AMD : 278.39 (+0.05%)
BAI : 40.82 (+2.00%)
CCJ : 120.66 (+0.32%)
DeepSeek Shakes US Tech Dominance: Impact on Stocks & ETFs

The technology sector, which had been enjoying a huge AI boom, saw a bloodbath on Monday, triggered by the emergence of DeepSeek, a China-based artificial intelligence (AI) startup that threatens to disrupt...

NVDA : 201.68 (+1.68%)
DAPP : 19.38 (+4.53%)
SMCL : 2.61 (+0.77%)
PSI : 120.04 (+3.26%)
SEMI : 33.83 (+1.50%)
ARTY : 58.65 (+1.73%)
BAI : 40.82 (+2.00%)
AIS : 53.43 (+2.75%)
TSMY : 16.10 (+1.19%)
SMHX : 46.50 (+2.58%)
SMH : 464.16 (+2.06%)
SHOC : 88.75 (+2.20%)
BenevolentAI: Notice of Preliminary Results

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, will announce its preliminary results for the year ended 31...

BAI : 40.82 (+2.00%)
BenevolentAI to Present at the Cowen 43rd Annual Health Care Conference

BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will present at the Cowen 43rd Annual Health Care Conference, which will be held in Boston...

BAI : 40.82 (+2.00%)
BenevolentAI to Present at 41st Annual J.P. Morgan Healthcare Conference

BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San...

BAI : 40.82 (+2.00%)
BenevolentAI Group: Analyst / Investor Event and Interim Results

/PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, is...

BAI : 40.82 (+2.00%)
BenevolentAI Group: Notice of Interim Results and Analyst / Investor Event

/PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, will...

BAI : 40.82 (+2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Fund Summary

The iShares A.I. Innovation and Tech Active ETF seeks to maximize total return.

See More

Key Turning Points

3rd Resistance Point 41.48
2nd Resistance Point 41.17
1st Resistance Point 40.99
Last Price 40.82
1st Support Level 40.50
2nd Support Level 40.19
3rd Support Level 40.01

See More

52-Week High 40.85
Last Price 40.82
Fibonacci 61.8% 32.77
Fibonacci 50% 30.27
Fibonacci 38.2% 27.78
52-Week Low 19.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.